Letters to the Editor

Atypical acute promyelocytic leukemia with tripartite fusion gene PML::RARG::LINE-L2a is resistant to ATRA but sensitive to arsenic-based therapy

Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Blood Transfusion, First Affiliated Hospital of Nanchang University, Jiangxi Key Laboratory of transfusion, Institute of Transfusion, Jiangxi Academy of Clinical Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi
Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang
Department of Blood Transfusion, First Affiliated Hospital of Nanchang University, Jiangxi Key Laboratory of transfusion, Institute of Transfusion, Jiangxi Academy of Clinical Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi
Haematologica Early view Jun 12, 2025 https://doi.org/10.3324/haematol.2025.287318